Breeze Holdings ups PIPE investment to $30M in YD Biopharma merger

Breeze Holdings Acquisition Corp.

Amendment increases PIPE investment from $15M to $30M, effective May 30, 2025.
PIPE closing conditioned on contemporaneous merger closing and regulatory approvals.
Pubco to issue ordinary shares and provide registration rights to PIPE investors.
Other terms of the Merger Agreement remain unchanged; transaction proceeds as planned.

item 1.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.